SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000920465-15-000017
Filing Date
2015-04-08
Accepted
2015-04-08 19:21:29
Documents
1
Period of Report
2015-04-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_142853527898925.html 3  
1 FORM 3 wf-form3_142853527898925.xml 3 1711
  Complete submission text file 0000920465-15-000017.txt   2984
Mailing Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address
MULROY DENNIS (Reporting) CIK: 0001276840 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36282 | Film No.: 15760106